34.37% 0.0849

Vaxart Inc (VXRT)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測株式分割株の配当実績

Vaxart Inc (VXRT) 最新ニュース

Vaxart Inc (VXRT)

Vaxart Inc (VXRT) 最新ニュース

Vaxart, Inc.(NasdaqCM: VXRT) dropped from S&P TMI Index - MarketScreener

Vaxart, Inc.(NasdaqCM: VXRT) dropped from S&P Global BMI Index - MarketScreener

Vaxart Stock Approved for OTCQX Best Market - The Globe and Mail

OTC Markets Group Welcomes Vaxart, Inc. to OTCQX - GlobeNewswire

Vaxart Investors Can Pursue Suit Over COVID Vax Claims - Law360

Vaxart Insiders Lose Bid to Thwart Trial in Investor Class Suit - Bloomberg Law News

Vaxart Announces Trading on OTCQX Best Market - GlobeNewswire

Vaxart Moves to OTCQX Best Market While Fighting Nasdaq DelistingWhat Investors Should Know - Stock Titan

Vaxart's OTCQX Shift: A Strategic Pivot to Fuel Disruptive Innovation in Oral Vaccines - AInvest

Vaxart begins trading on OTCQX Best Market after Nasdaq exit - Proactive financial news

Vaxart to be suspended from Nasdaq, plans to appeal delisting decision By Investing.com - Investing.com South Africa

Vaxart, Inc. (NASDAQ:VXRT) Stock Catapults 34% Though Its Price And Business Still Lag The Industry - simplywall.st

Vaxart Announces Preliminary Results of Annual Meeting of Stockh - GuruFocus

Vaxart, Inc. Announces Results from 2025 Annual Meeting of Stockholders - Nasdaq

Vaxart Announces Preliminary Results of Annual Meeting of Stockholders - The Manila Times

Vaxart Faces Nasdaq Challenge as Shareholders Block Reverse Split Proposal at Annual Meeting - Stock Titan

Oppenheimer Remains a Buy on Vaxart (VXRT) - The Globe and Mail

Vaxart reports improved antibody response in norovirus vaccine trial By Investing.com - Investing.com India

Biotech Steals The Mid-Week Spotlight With Key Announcement - The Globe and Mail

Vaxart (VXRT) Unveils Promising Phase 1 Results for New Noroviru - GuruFocus

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discu - GuruFocus

Vaxart Jumps 38% After Positive Norovirus Trial - Yahoo Finance

Vaxart soars on positive data from new norovirus vaccine trial - MSN

Vaxart (VXRT) Shares Soar After Promising Norovirus Vaccine Tria - GuruFocus

Vaxart, DoubleVerify, Cracker Barrel - TradingView

Vaxart stock soars after positive Phase 1 norovirus vaccine results By Investing.com - Investing.com South Africa

Vaxart's Oral Norovirus Vaccine Pills Meet Primary Immunological Endpoint in Phase 1 Trial - marketscreener.com

Sector Update: Health Care Stocks Higher Pre-Bell Wednesday - MarketScreener

Vaxart stock soars after positive Phase 1 norovirus vaccine results - Investing.com

Vaxart reports improved antibody response in norovirus vaccine trial - Investing.com Australia

Vaxart Reports Positive Clinical Data Demonstrating that its Sec - GuruFocus

Vaxart Reports Positive Clinical Data Demonstrating Second-Generation Vaccine Technology Produces Stronger Antibody Responses Than First-Generation - marketscreener.com

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology - The Manila Times

Vaxart Reports Positive Clinical Data Demonstrating that - GlobeNewswire

Breakthrough: New Oral Pill Vaccine Technology Delivers 141% Stronger Immune Response Against Norovirus - Stock Titan

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial - GlobeNewswire

Vaxart to Reveal First-Ever Oral Norovirus Vaccine Trial Results: Key Data Coming Tomorrow - Stock Titan

Vaxart, Inc. (NASDAQ:VXRT) Shares Bought by Squarepoint Ops LLC - Defense World

Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 | VXRT Stock News - GuruFocus

Vaxart, Inc. (NASDAQ:VXRT) Sees Significant Increase in Short Interest - Defense World

Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart - Business Wire

Millennium Management LLC Decreases Stock Holdings in Vaxart, Inc. (NASDAQ:VXRT) - Defense World

Vaxart Announces Adjournment of Annual Meeting of Stockholders | - GuruFocus

Vaxart Announces Adjournment Of Annual Meeting Of Stockholders - marketscreener.com

Vaxart Announces Adjournment of Annual Meeting of Stockholders | VXRT Stock News - GuruFocus

Vaxart Annual Meeting Adjourned to June 13, 2025; Proxy Advisory Firms Support Proposal No. 2 - Nasdaq

Vaxart Announces Adjournment of Annual Meeting of Stockholders - GlobeNewswire

B. Riley Has Positive Forecast for Vaxart Q3 Earnings - Defense World

FY2029 Earnings Estimate for Vaxart Issued By B. Riley - Defense World

Oral Pill Norovirus Vaccine Candidate Posts Positive Phase 2b Challenge Study Results - Vax-Before-Travel

Vaxart stock climbs on positive study of pill-based norovirus vaccine - MSN

Zoom Rises 8% in 3 Months: Here's Why You Should Buy the Stock Now - The Globe and Mail

Vaxart seeks shareholder nod for reverse stock split By Investing.com - Investing.com South Africa

VXRTに似た銘柄